Metastases to bone and Lymphocyte count increased

Summary:

Lymphocyte count increased is found among people with Metastases to bone, especially for people who are female, 60+ old.

The study analyzes which people have Lymphocyte count increased with Metastases to bone. It is created by eHealthMe based on reports of 15 people who have Metastases to bone from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastases to bone?

Metastases to bone (cancer spreads to bone) is found to be associated with 1,127 drugs and 902 conditions by eHealthMe. Check the latest studies of Metastases to bone.

What is Lymphocyte count increased?

Lymphocyte count increased is found to be associated with 473 drugs and 611 conditions by eHealthMe. Check the latest studies of Lymphocyte count increased.



On Jul, 30, 2026

15 people who have Metastases To Bone and Lymphocyte Count Increased are studied.

Would you have Lymphocyte count increased when you have Metastases to bone?

Gender of people who have Metastases To Bone and experienced Lymphocyte Count Increased *:

  • female: 53.33 %
  • male: 46.67 %

Age of people who have Metastases To Bone and experienced Lymphocyte Count Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.67 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 60.0 %

Common co-existing conditions for these people *:

  1. Prostate Cancer: 2 people, 13.33%
  2. Indigestion: 2 people, 13.33%
  3. Prostate Cancer Metastatic: 1 person, 6.67%
  4. Pain: 1 person, 6.67%
  5. Metastases To Lung (cancer spreads to lung): 1 person, 6.67%
  6. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.67%
  7. Breast Cancer Recurrent: 1 person, 6.67%
  8. Breast Cancer: 1 person, 6.67%
  9. Asthma: 1 person, 6.67%

Common drugs taken by these people *:

  1. Zometa: 12 people, 80.00%
  2. Taxotere: 3 people, 20.00%
  3. Lyrica: 1 person, 6.67%
  4. Albuterol: 1 person, 6.67%
  5. Aredia: 1 person, 6.67%
  6. Boniva: 1 person, 6.67%
  7. Celebrex: 1 person, 6.67%
  8. Ciloxan: 1 person, 6.67%
  9. Femara: 1 person, 6.67%
  10. Frova: 1 person, 6.67%

Common symptoms for these people *:

  1. White Blood Cell Count Increased: 10 people, 66.67%
  2. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 10 people, 66.67%
  3. Carbohydrate Antigen 125 Increased: 7 people, 46.67%
  4. Blood Creatinine Increased: 7 people, 46.67%
  5. Carbohydrate Antigen 15-3 Increased: 7 people, 46.67%
  6. Glomerular Filtration Rate Decreased: 7 people, 46.67%
  7. Metamyelocyte Count Increased (excess precursor in the granulocytic series): 7 people, 46.67%
  8. Visual Impairment: 7 people, 46.67%
  9. Diplopia (double vision): 7 people, 46.67%
  10. Fever: 6 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lymphocyte count increased?

- Check whether Lymphocyte count increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Lymphocyte count increased:

All the conditions that are associated with Lymphocyte count increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lymphocyte count increased and Metastases to bone, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: